Flputnam Investment Management Co. Acquires Shares of 33,778 CVS Health Corporation $CVS

Posted by Stanley Muller on Aug 17th, 2026

Flputnam Investment Management Co. purchased a new position in shares of CVS Health Corporation (NYSE:CVS – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 33,778 shares of the pharmacy operator’s stock, valued at approximately $3,494,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $2,825,000. 1ST Source Bank acquired a new stake in CVS Health during the second quarter worth about $1,248,000. Fielder Capital Group LLC acquired a new stake in CVS Health during the second quarter worth about $618,000. Silverlake Wealth Management LLC purchased a new position in CVS Health during the second quarter worth about $844,000. Finally, Bank of New York Mellon Corp acquired a new position in CVS Health in the 2nd quarter valued at about $932,454,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.1%

CVS Health stock opened at $97.09 on Monday. The company has a market capitalization of $124.18 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. CVS Health Corporation has a fifty-two week low of $67.42 and a fifty-two week high of $110.68. The firm has a 50 day moving average price of $102.52 and a 200 day moving average price of $88.26.

CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm’s revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. CVS Health’s payout ratio is 70.37%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. DA Davidson raised their price target on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Bank of America upped their price objective on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Sanford C. Bernstein raised their target price on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Piper Sandler restated an “overweight” rating and issued a $113.00 target price on shares of CVS Health in a research report on Monday, June 1st. Finally, Royal Bank Of Canada upped their price target on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $106.75.

Read Our Latest Stock Report on CVS Health

Insider Buying and Selling at CVS Health

In related news, Director Larry Robbins sold 370,462 shares of CVS Health stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the transaction, the director directly owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. This trade represents a 7.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold a total of 3,372,000 shares of company stock worth $317,473,598 over the last 90 days. 0.85% of the stock is currently owned by corporate insiders.

CVS Health Profile

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.